BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

VirtualScopics, LLC' Chief Financial Officer to Resign


6/17/2013 8:40:55 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROCHESTER, N.Y., June 14, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced that on June 12, 2013 Molly Henderson, its Chief Business and Financial Officer, Sr. Vice President notified the company of her intention to resign from the company effective August 31st, 2013 due to the relocation of her family to Europe. Ms. Henderson will continue in her current role until August 31, 2013.

Jeff Markin, President and Chief Executive Officer of VirtualScopics stated, "Molly has made a significant impact on the company and our employees during her greater than 10 years with the organization. During her tenure the company has achieved revenue growth in excess of 500% while moving from a cash consuming privately held organization to one that is a publicly traded company listed on NASDAQ. Molly was a key driver of these achievements." He added, "On a more personal note Molly has been a true partner of mine in leading the company through some very exciting as well as challenging times and was the initial architect of our strategy to expand into personalized medicine. We thank her for her leadership and wish her and her family well as they embark on their relocation to Europe."

Further, Robert Klimasewski, Chairman of the Board of VirtualScopics stated, "Molly is a very talented executive who has made significant contributions to the company. The board has relied on her judgments and insights in making important decisions. We wish her well in her next endeavors."

The company has initiated a search for a new Chief Financial Officer.

About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit www.virtualscopics.com.




CONTACTS:

Investor Relations:

Company Contact:


Tim Ryan

Jeff Markin


The Shoreham Group

President and CEO


80 Eighth Ave, Ste 1107

500 Linden Oaks


New York, NY 10011

Rochester, New York 14625


+1 212 242 7777 Direct

+1 585 249.6231


tryan@shorehamgroupllc.com





SOURCE VirtualScopics, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES